BI Asset Management Fondsmaeglerselskab’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $773K | Buy |
|
|||||
|
2025
Q1 | $897K | Sell |
|
|||||
|
2024
Q4 | $1.84M | Buy |
|
|||||
|
2024
Q3 | $1.85M | Buy |
|
|||||
|
2024
Q2 | $179K | Sell |
|
|||||
|
2024
Q1 | $500K | Sell |
|
|||||
|
2023
Q4 | $824K | Buy |
|
|||||
|
2023
Q3 | $275K | Hold |
|
|||||
|
2023
Q2 | $269K | Buy |
|
|||||
|
2023
Q1 | $131K | Sell |
|
|||||
|
2022
Q4 | $609K | Buy |
|
|||||
|
2022
Q3 | $495K | Buy |
|
|||||
|
2022
Q2 | $405K | Hold |
|
|||||
|
2022
Q1 | $377K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $70K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $131K | Sell |
|
|||||
|
2019
Q3 | $306K | Buy |
|
|||||
|
2019
Q2 | $300K | Buy |
|